Award
National Heart, Lung, and Blood Institute 11260216
Regulation of SGK1-mediated Pathological Cardiac Hypertrophy by Non-Canonical ERAD
Recipient
National Heart Lung and Blood Institute (NHLBI)
Award Amount
$41,731.00
Ceiling
$41,731.00
Awarded
May 08, 2026
Identifier
11260216
Research project awarded by NHLBI to study SGK1's role in cardiac hypertrophy and its regulation through ERAD, aiming to identify therapeutic targets.
Description
The project focuses on studying the role of SGK1 in cardiac hypertrophy and its regulation via ERAD. The project involves experiments with primary cultured cardiac myocytes and mouse models. The goal is to determine if SGK1 is a promising therapeutic target for cardiac hypertrophy.